Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Nov;33(11):649-53.
doi: 10.1007/BF00400565.

Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells

Affiliations

Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells

C F Van Schravendijk et al. Diabetologia. 1990 Nov.

Abstract

Purified pancreatic Beta cells were labelled with 3H-tyrosine before studying their secretory activity in perifusion. At 1.4 mmol/l glucose, the cells released similar fractions (0.01% per min) of their contents in preformed and in newly formed insulin. At 20 mmol/l glucose plus 10(-8) mol/l glucagon, these fractional release rates increased by 16 and 40-fold respectively. The preferential release of newly synthesized as compared to stored insulin is attributable to a heterogeneity in individual cell responses. The secretory responsiveness to glucose plus glucagon was completely suppressed by 10(-7) mol/l clonidine. Insulin induced a 20% reduction at 10(-6) mol/l, but remained without effect at 10(-7) mol/l. Insulin-like growth factor-I provoked a 30% decrease at 5.10(-9) mol/l. It is concluded that the type-I insulin-like growth factor receptors on pancreatic Beta cells mediate a suppressive action on the insulin release process. Their high affinity for insulin-like growth factor-I allows physiologic levels of this peptide to participate in the regulation of insulin release. Their low affinity for insulin provides the basis for a minor feedback action by this hormone at concentrations exceeding the normal circulating levels.

PubMed Disclaimer

References

    1. Endocrinology. 1976 Dec;99(6):1469-76 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7322-5 - PubMed
    1. Proc Soc Exp Biol Med. 1969 Feb;130(2):568-71 - PubMed
    1. J Cell Physiol. 1985 Jan;122(1):133-41 - PubMed
    1. Diabetes. 1973 May;22(5):354-60 - PubMed

Publication types

LinkOut - more resources